U.S. Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Ulipristal Acetate), By Distribution Channel (Retail Store, Online Store), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                          1.1.1. Market Definitions
                      1.2. Estimates and Forecast Timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased Database
                          1.4.2. GVR’s Internal Database
                          1.4.3. Secondary Sources & Third-Party Perspectives
                          1.4.4. Primary Research
                      1.5. Information Analysis
                          1.5.1. Data Analysis Models
                      1.6. Market Formulation & Data Visualization
                      1.7. Model Details
                          1.7.1. Commodity Flow Analysis
                      1.8. List of Secondary Sources
Chapter 2. Executive Summary
                      2.1. Market Snapshot
                      2.2. Segment Snapshot
                      2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent Market Outlook
                          3.1.2. Related/Ancillary Market Outlook
                      3.2. Market Trends and Outlook
                      3.3. Market Dynamics
                          3.3.1. Market Driver Analysis
                              3.3.1.1. Increasing awareness about emergency contraception methods
                              3.3.1.2. Rising prevalence of unintended pregnancies
                              3.3.1.3. Increased focus on women's health by the government and non-government organizations.
                          3.3.2. Market Restraint Analysis
                              3.3.2.1. Product recall
                              3.3.2.2. Adverse effects associated with the use of contraceptive drugs
                      3.4. Business Environment Analysis
                          3.4.1. PESTLE Analysis
                          3.4.2. Porter’s Five Forces Analysis
                      3.5. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
                              4.1. U.S. Emergency Contraceptive Pills Market: Type Movement Analysis & Market Share, 2022 & 2030
                              4.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
                      4.3. Combination Pills
                          4.3.1. Combination Pills Market, 2018 - 2030 (USD Million)
                      4.4. Progesterone Pills
                          4.4.1. Progesterone Pills Market, 2018 - 2030 (USD Million)
                      4.5. Ulipristal Acetate
                          4.5.1. Ulipristal Acetate Market, 2018 - 2030 (USD Million)
Chapter 5. Distribution Channel Business Analysis
                              5.1. U.S. Emergency Contraceptive Pills Market: Distribution Channel Movement Analysis & Market Share, 2022 & 2030
                              5.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
                      5.3. Retail Store
                          5.3.1. Retail Store Market, 2018 - 2030 (USD Million)
                      5.4. Online Store
                          5.4.1. Online Store Market, 2018 - 2030 (USD Million)
                      5.5. Others
                          5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
                              6.1. U.S. Emergency Contraceptive Pills Market by Region, 2022 & 2030
                      6.2. Northeast
                          6.2.1. Northeast Market, 2018 - 2030 (USD Million)
                      6.3. Southeast
                          6.3.1. Southeast Market, 2018 - 2030 (USD Million)
                      6.4. Midwest
                          6.4.1. Midwest Market, 2018 - 2030 (USD Million)
                      6.5. West
                          6.5.1. West Market, 2018 - 2030 (USD Million)
                      6.6. Southwest
                          6.6.1. Southwest Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                      7.1. Company Categorization
                      7.2. Strategy Mapping
                          7.2.1. Expansion
                          7.2.2. Acquisition
                          7.2.3. Collaborations
                          7.2.4. New Product Launches
                          7.2.5. Others
                      7.3. Company Profiles/Listing
                          7.3.1. Afaxys Pharma LLC
                              7.3.1.1. Overview
                              7.3.1.2. Financial Performance
                              7.3.1.3. Product Benchmarking
                              7.3.1.4. Strategic Initiatives
                          7.3.2. Teva Pharmaceutical Industries Ltd.
                              7.3.2.1. Overview
                              7.3.2.2. Financial Performance
                              7.3.2.3. Product Benchmarking
                              7.3.2.4. Strategic Initiatives
                          7.3.3. Syzygy Healthcare, LLC
                              7.3.3.1. Overview
                              7.3.3.2. Financial Performance
                              7.3.3.3. Product Benchmarking
                              7.3.3.4. Strategic Initiatives
                          7.3.4. Gedeon Richter USA, Inc.
                              7.3.4.1. Overview
                              7.3.4.2. Financial Performance
                              7.3.4.3. Product Benchmarking
                              7.3.4.4. Strategic Initiatives
                          7.3.5. Rapha Pharmaceuticals, Inc.
                              7.3.5.1. Overview
                              7.3.5.2. Financial Performance
                              7.3.5.3. Product Benchmarking
                              7.3.5.4. Strategic Initiatives
                          7.3.6. Perrigo Company plc.
                              7.3.6.1. Overview
                              7.3.6.2. Financial Performance
                              7.3.6.3. Product Benchmarking
                              7.3.6.4. Strategic Initiatives
                          7.3.7. Foundation Consumer Healthcare LLC
                              7.3.7.1. Overview
                              7.3.7.2. Financial Performance
                              7.3.7.3. Product Benchmarking
                              7.3.7.4. Strategic Initiatives
                          7.3.8. Wockhardt USA
                              7.3.8.1. Overview
                              7.3.8.2. Financial Performance
                              7.3.8.3. Product Benchmarking
                              7.3.8.4. Strategic Initiatives
                          7.3.9. Pfizer Inc.
                              7.3.9.1. Overview
                              7.3.9.2. Financial Performance
                              7.3.9.3. Product Benchmarking
                              7.3.9.4. Strategic Initiatives
                          7.3.10. Bayer plc
                              7.3.10.1. Overview
                              7.3.10.2. Financial Performance
                              7.3.10.3. Product Benchmarking
                              7.3.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. Emergency Contraceptive Pills market, by Type, 2018 - 2030 (USD Million)
Table 4. U.S. Emergency Contraceptive Pills market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 5. U.S. Emergency Contraceptive Pills market, by Region, 2018 - 2030 (USD Million)

List of Figures

Fig 1. Market research process
Fig 2. Information procurement
Fig 3. Primary research pattern
Fig 4. Market research approaches
Fig 5. Value chain-based sizing & forecasting
Fig 6. Market formulation & validation
Fig 7. U.S. emergency contraceptive pills market segmentation
Fig 8. Market snapshot, 2022
Fig 9. Segment snapshot
Fig 10. Competitive landscape snapshot
Fig 11. Market trends & outlook
Fig 12. Market driver relevance analysis (current & future impact)
Fig 13. Market restraint relevance analysis (current & future impact)
Fig 14. PESTLE analysis
Fig 15. Porter’s five forces analysis
Fig 16. U.S. emergency contraceptive pills market: Type outlook and key takeaways
Fig 17. U.S. emergency contraceptive pills market: Type movement analysis
Fig 18. Combination pills market revenue, 2018 - 2030 (USD Million)
Fig 19. Progesterone pills market revenue, 2018 - 2030 (USD Million)
Fig 20. Ulipristal acetate market revenue, 2018 - 2030 (USD Million)
Fig 21. U.S. emergency contraceptive pills market: Distribution channel outlook and key takeaways
Fig 22. U.S. emergency contraceptive pills market: Distribution channel movement analysis
Fig 23. Retail store market revenue, 2018 - 2030 (USD Million)
Fig 24. Online store market revenue, 2018 - 2030 (USD Million)
Fig 25. Others market revenue, 2018 - 2030 (USD Million)
Fig 26. U.S. emergency contraceptive pills market: Regional outlook and key takeaways
Fig 27. U.S. emergency contraceptive pills market: Regional movement analysis
Fig 28. Northeast market revenue, 2018 - 2030 (USD Million)
Fig 29. Southeast market revenue, 2018 - 2030 (USD Million)
Fig 30. Midwest market revenue, 2018 - 2030 (USD Million)
Fig 31. West market revenue, 2018 - 2030 (USD Million)
Fig 32. Southwest market revenue, 2018 - 2030 (USD Million)
Fig 33. Company categorization
Fig 34. Strategy mapping
Fig 35. Company market position analysis